Document is current
Any future updates will be listed below
-
Authors
Kandathil, Abraham J. https://orcid.org/0000-0002-9038-134X
Cox, Andrea L.
Page, Kimberly
Mohr, David
Razaghi, Roham
Ghanem, Khalil G.
Tuddenham, Susan A.
Hsieh, Yu-Hsiang
Evans, Jennifer L.
Coller, Kelly E.
Timp, Winston https://orcid.org/0000-0003-2083-6027
Celentano, David D.
Ray, Stuart C. https://orcid.org/0000-0002-1051-7260
Thomas, David L.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA01380)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R21DA053145)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA16017)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U19AI159822)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
- License Information
-
More Information
Article History
Received: 28 April 2021
Accepted: 25 October 2021
First Online: 25 November 2021
Competing interests
: S.T. has been a consultant for Biofire Diagnostics, Roche Molecular Diagnostics and Luca Biologics, and has received speaker honoraria from Roche Molecular Diagnostics. All other authors declare no competing interests.
